Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease symptoms in this underserved patient populationADAPT SERON,...
-
MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025_____ Paris, le 17 avril 2026 (22h00) - ADLPartner, société mère du Groupe DÉKUPLE Leader Européen de la Communication et du Data Marketing, annonce...
-
LONDON, 17 Apr. 2026 (GLOBE NEWSWIRE) -- This is the End of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
-
Transaction in Own Shares 17 April 2026 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 17 April 2026 it purchased the following number of Shares for cancellation. ...
-
-
-
Transparantieverklaring van Amundi SA In overeenstemming met artikel 14, § 1 van de wet van 2 mei 2007 betreffende de openbaarmaking van belangrijke deelnemingen, werd Umicore onlangs op de hoogte...
-
Déclaration de transparence par Amundi SA Conformément à l'article 14, § 1 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Umicore a récemment été notifiée par Amundi...
-
Transparency notification by Amundi SA In accordance with article 14, § 1 of the law of 2 May 2007 on the disclosure of major holdings, Umicore was recently notified by Amundi SA that it has crossed...
-
Azerion Group publishes its 2025 Annual Report Amsterdam, 17 April 2026 - Azerion Group N.V. (EURONEXT: AZRN) today published its audited 2025 Annual Report. The 2025 Annual Report has been filed...